SCHEDULE 13G

Company

Mirum Pharmaceuticals, Inc.

Filed

September 18, 2023

Accession Number

0000921895-23-002186

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →